Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in... see more

Recent & Breaking News (GREY:LXXGQ)

Uptick Newswire Hosts LexaGene Holdings Inc. on The Stock Day Podcast to Discuss the Beta Launch of Their Pathogen Detection Device

Accesswire April 24, 2019

LexaGene's Technology Identifies Genetic Mutations Directly from Cheek Swabs

GlobeNewswire April 24, 2019

Former Head of Food Safety at Chipotle Mexican Grills Joins LexaGene’s Scientific Advisory Board

GlobeNewswire April 3, 2019

LexaGene’s Closes Oversubscribed Private Placement

GlobeNewswire March 29, 2019

LexaGene Announces C$1.95 Million Private Placement

GlobeNewswire March 13, 2019

LexaGene’s CEO Invited by USDA to Present a Seminar on the Benefits of Adopting Rapid Genetic Testing to Improve Food Safety

GlobeNewswire March 11, 2019

LexaGene’s LX Technology Successfully Detects Pathogenic E. coli O157:H7 Bacteria from Romaine Lettuce Wash

GlobeNewswire March 5, 2019

LexaGene Completes Pilot Clinical Study and Reports Results

GlobeNewswire February 25, 2019

LexaGene’s Technology Successfully Detects Antibiotic Resistance Factors

GlobeNewswire February 12, 2019

LexaGene’s Technology Successfully Detects Dual Infected Samples

GlobeNewswire February 7, 2019

LexaGene Starts Clinical Study Using its Technology

GlobeNewswire February 4, 2019

LexaGene Announces Formation of Scientific Advisory Board

GlobeNewswire January 22, 2019

LexaGene Featured on ABC Affiliate WCVB-TV Boston

GlobeNewswire January 3, 2019

LexaGene Completes Development of Canine UTI Syndromic Panel

GlobeNewswire December 10, 2018

LexaGene Attends Industry Engagement Meeting with the Department of Homeland Security

GlobeNewswire December 3, 2018

LexaGene Named One of the 10 Most Promising Food Solution Providers

GlobeNewswire November 28, 2018

LX2 Prototype Model Unveiled at AAVLD

GlobeNewswire October 22, 2018

LexaGene To Unveil LX2™ Beta Prototype Design for the Veterinary Market

GlobeNewswire October 9, 2018

LexaGene to Present at Two Upcoming Investor Conferences

GlobeNewswire September 4, 2018

LexaGene Begins Beta Development of Pathogen Detection System

GlobeNewswire July 26, 2018